http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9112004-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1991-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6de564e0b42ed785cf3e9076731fd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66406059e1e9bcea4832a0c25e5dcf84 |
| publicationDate | 1991-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9112004-A1 |
| titleOfInvention | Topical use of 6-n-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenanthroline-2,8-dicarboxylic acid derivatives |
| abstract | The application concerns a method for the prophylaxis or treatment of inflammatory conditions initiated by an immune response, by topical administration of compounds of formula (I), wherein R?1 and R2¿ independently are hydroxyl, substituted or unsubstituted amino or -OR groups, wherein R is a substituted or unsubstituted aliphatic hydrocarbon group, or a pharmaceutically acceptable salt thereof. |
| priorityDate | 1990-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.